transcutan
immun
tci
noninvas
easytous
vaccin
method
demonstr
efficaci
safeti
transcutan
vaccin
formul
use
hydrogel
patch
anim
experi
present
studi
perform
clinic
studi
appli
tci
formul
vaccin
tetanu
diphtheria
human
tci
devic
hydrogel
patch
antigenfre
appli
left
brachial
medial
skin
healthi
volunt
h
next
hydrogel
patch
contain
mg
tetanu
toxoid
tt
mg
diphtheria
toxoid
dt
tci
formul
appli
healthi
volunt
h
volunt
vaccin
tci
formul
safeti
assess
patch
applic
site
observ
assess
local
advers
event
system
advers
event
determin
blood
test
antigenfre
hydrogel
patch
tci
formul
contain
tt
dt
induc
local
system
sever
advers
event
vaccin
efficaci
estim
toxoidspecif
serum
antibodi
titer
determin
elisa
toxinneutr
activ
induc
antibodi
evalu
passivechalleng
experi
antitt
igg
titer
antidt
igg
titer
increas
signific
effect
detect
pair
ttest
antibodi
titer
maintain
higher
level
vaccin
least
year
moreov
toxoidspecif
antibodi
produc
second
vaccin
subject
antibodi
induc
applic
tci
formul
neutral
toxin
prevent
toxic
death
mice
addit
chang
skin
condit
due
applic
tci
formul
observ
vivo
confoc
raman
spectroscopi
amount
water
patch
compon
stratum
corneum
increas
applic
tci
formul
suggest
chang
skin
condit
relat
antigen
penetr
data
indic
easytous
tci
system
induc
immun
respons
without
sever
advers
reaction
human
easytous
safe
tci
formul
enabl
mass
treatment
outbreak
set
increas
vaccin
rate
develop
countri
greatli
contribut
worldwid
countermeasur
infecti
diseas
vaccin
fundament
prophylaxi
ill
death
infecti
diseas
epidem
emerg
infecti
diseas
sever
acut
respiratori
syndrom
highli
pathogen
avian
influenza
threat
reemerg
infecti
diseas
tuberculosi
malaria
emphas
import
vaccin
one
exampl
global
threat
infecti
diseas
recent
outbreak
new
influenza
declar
phase
pandem
statu
world
health
organ
june
avail
novel
vaccin
method
urgent
need
outset
pandem
bioterror
attack
convent
inject
vaccin
associ
sever
problem
pain
requir
medic
personnel
techniqu
needlerel
diseas
injuri
storag
transport
issu
need
cold
chain
transcutan
immun
tci
attract
vaccin
method
elimin
problem
inject
vaccin
see
front
matter
elsevi
ltd
right
reserv
skin
target
organ
tci
contain
variou
immunocompet
cell
langerhan
cell
lc
keratinocyt
dermal
dendrit
cell
mast
cell
particular
lc
critic
role
potent
antigenpres
cell
extern
antigen
tci
must
deliv
antigen
protein
lc
epiderm
layer
induc
antigenspecif
immun
respons
difficult
howev
stratum
corneum
provid
physic
barrier
substanc
penetr
transcutan
vaccin
deliveri
techniqu
like
electropor
iontophoresi
includ
risk
inflamm
infect
result
damag
stratum
corneum
addit
method
requir
larges
specif
equip
use
vaccin
therefor
easytous
safe
tci
system
must
develop
costeffect
wide
avail
vaccin
previous
report
develop
tci
system
use
hydrogel
patch
deliv
antigen
protein
skin
without
destroy
remov
stratum
corneum
demonstr
lc
captur
antigen
protein
epiderm
layer
migrat
lymph
node
report
tci
formul
effect
induc
product
antigenspecif
antibodi
sever
model
antigen
addit
tci
formul
contain
tetanu
toxoid
tt
diphtheria
toxoid
dt
practic
antigen
induc
immun
respons
toxoidspecif
antibodi
produc
tci
formul
neutral
tetanu
diphtheria
toxin
moreov
side
effect
observ
anim
experi
base
draiz
score
patholog
examin
blood
test
thu
vaccin
use
tci
formul
effect
also
safe
believ
tci
system
appli
human
base
previou
result
conduct
clinic
studi
tci
system
use
hydrogel
patch
show
tci
formul
practic
novel
vaccin
system
evalu
safeti
efficaci
vaccin
tetanu
diphtheria
human
femal
icr
mice
week
old
purchas
slc
inc
hamamatsu
japan
mice
maintain
experiment
anim
facil
osaka
univers
experi
conduct
accord
guidelin
provid
anim
care
use
committe
osaka
univers
hydrogel
patch
formul
compris
crosslink
hipa
tm
acryl
medic
adhes
cosm
pharmaceut
co
ltd
kyoto
japan
octyldodecyl
lactat
glycerin
sodium
hyaluronan
weight
ratio
composit
prepar
describ
previous
twentytwo
healthi
volunt
year
old
asian
peopl
japanes
male
femal
enrol
studi
inform
consent
obtain
volunt
enrol
clinic
procedur
approv
ethic
committe
nara
medic
univers
tci
devic
compris
antigenfre
hydrogel
patch
cm
cm
appli
left
brachial
medial
skin
volunt
h
cover
wound
protect
film
libatap
pharmaceut
co
ltd
kumamoto
japan
allow
better
skin
adher
fig
fortyeight
hour
patch
applic
patch
remov
investig
site
skin
irrit
reaction
score
accord
classif
intern
contact
dermat
research
group
icdrg
assess
local
advers
event
h
h
appli
patch
blood
sampl
collect
h
h
gener
peripher
blood
test
biochem
test
liver
renal
function
perform
evalu
presenc
system
advers
reaction
addit
volunt
interview
regard
presenc
subject
symptom
period
volunt
instruct
avoid
activ
might
influenc
investig
site
twentyseven
healthi
volunt
year
old
asian
peopl
japanes
male
femal
enrol
studi
inform
consent
obtain
volunt
enrol
clinic
procedur
approv
ethic
committe
nara
medic
univers
toxoid
solut
contain
mg
tt
mg
dt
lot
number
tt
dt
research
foundat
microbi
diseas
osaka
univers
suita
japan
phosphatebuff
salin
drop
surfac
hydrogel
patch
cm
cm
water
absorb
asept
condit
hydrogel
patch
contain
tt
dt
tci
formul
appli
left
brachial
medial
skin
volunt
h
cover
wound
protect
film
allow
better
skin
adher
fig
fig
summar
vaccin
protocol
use
tci
formul
twentyfour
hour
applic
tci
formul
remov
investig
site
skin
irrit
reaction
score
accord
classif
icdrg
assess
local
advers
respons
h
h
gener
peripher
blood
test
biochem
test
liver
renal
function
perform
h
h
evalu
presenc
system
advers
respons
addit
volunt
interview
assess
presenc
subject
symptom
period
volunt
instruct
avoid
activ
might
influenc
investig
site
sixti
day
applic
tci
formul
serum
collect
subject
measur
toxoidspecif
antibodi
titer
addit
second
vaccin
subject
administ
day
first
vaccin
use
procedur
icdrg
score
perform
day
blood
test
perform
day
evalu
possibl
side
effect
induc
second
vaccin
measur
antibodi
product
induc
second
vaccin
serum
collect
day
moreov
assess
longterm
vaccin
effect
serum
collect
subject
day
first
vaccin
ttor
dtspecif
serum
igg
titer
measur
use
elisa
kit
tetanu
igg
elisa
diphtheria
igg
elisa
ibl
intern
gmbh
hamburg
germani
accord
manufactur
instruct
serum
igg
titer
express
intern
unit
per
millilit
iuml
test
sera
collect
subject
day
icr
mice
inject
subcutan
mixtur
test
serum
dilut
dilut
factor
l
solut
contain
lethal
amount
ng
tetanu
toxin
sigmaaldrich
inc
st
loui
mo
incub
c
h
mice
monitor
surviv
week
raman
spectra
rang
depth
skin
surfac
record
use
vivo
confoc
raman
spectroscopi
model
skin
composit
analyz
river
diagnost
rotterdam
netherland
subject
left
brachial
medial
skin
measur
immedi
h
remov
hydrogel
patch
contain
tt
dt
control
raman
spectra
right
brachial
medial
skin
untreat
skin
collect
water
content
mass
stratum
corneum
determin
water
protein
ratio
obtain
raman
signal
intens
raman
spectra
measur
skin
compon
natur
moistur
factor
lactat
acid
ceramid
compon
hydrogel
patch
glycerin
amount
express
rel
keratin
concentr
procedur
conduct
report
casper
et
al
antibodi
analysi
perform
use
natur
logarithm
antibodi
valu
pair
ttest
analysi
raw
data
follow
gaussian
distribut
skin
condit
analysi
valu
time
point
compar
use
steeldwass
test
everi
effect
develop
tci
tci
devic
safe
applic
human
previous
confirm
tci
formul
induc
side
effect
anim
experi
accordingli
estim
hydrogel
patch
safe
tci
devic
human
base
degre
skin
irrit
system
advers
effect
immedi
patch
remov
score
subject
classifi
neg
tabl
although
patch
applic
caus
faint
erythema
subject
reaction
disappear
complet
within
h
patch
remov
addit
patch
applic
system
advers
effect
determin
gener
peripher
blood
test
biochem
test
liver
renal
function
tabl
none
subject
describ
particularli
advers
symptom
thu
conclud
hydrogel
patch
safe
human
tci
use
hydrogel
patch
promis
applic
without
local
system
advers
effect
prepar
novel
tci
formul
contain
tt
dt
use
hydrogel
patch
verifi
safe
vaccin
devic
human
tt
dt
use
practic
world
antigen
protein
inject
vaccin
examin
safeti
tci
formul
human
half
subject
score
neg
reaction
h
applic
tabl
faint
erythema
elicit
subject
weak
posit
reaction
observ
subject
although
number
posit
subject
increas
within
h
remov
tci
formul
subject
describ
itch
sensat
irrit
respons
disappear
sever
day
later
addit
system
advers
respons
recogn
gener
peripher
blood
test
biochem
test
liver
renal
function
tabl
second
vaccin
tend
induc
similar
local
system
advers
respons
tabl
taken
togeth
find
indic
tci
formul
use
hydrogel
patch
appli
human
without
induc
sever
side
reaction
confirm
safeti
hydrogel
patch
contain
antigen
protein
human
next
evalu
efficaci
tci
formul
tetanu
diphtheria
shown
tabl
fig
antitt
igg
antidt
igg
increas
pair
ttest
p
follow
first
vaccin
use
tci
formul
indic
singl
applic
tci
formul
could
induc
immun
respons
human
also
administ
second
vaccin
subject
neither
antibodi
titer
significantli
increas
first
vaccin
igg
titer
increas
part
subject
follow
second
vaccin
suggest
addit
applic
increas
efficaci
tci
formul
tabl
fig
b
antibodi
titer
day
applic
tci
formul
maintain
higher
level
day
subject
examin
although
antibodi
titer
tend
lower
day
day
tabl
fig
moreov
evalu
toxinneutr
effect
induc
antibodi
perform
passivechalleng
experi
tetanu
toxin
use
sera
subject
whose
antibodi
level
increas
first
vaccin
maximum
dilut
factor
sera
neutral
toxin
day
higher
day
subject
examin
tabl
thu
tci
formul
induc
protect
immun
respons
bacteri
toxin
therefor
tci
formul
appear
applic
human
base
antibodi
product
singl
multipl
vaccin
longterm
vaccin
effect
toxinneutr
effect
use
vivo
confoc
raman
spectroscopi
analyz
condit
tci
applic
site
skin
molecular
level
immedi
remov
tci
formul
water
content
stratum
corneum
near
skin
surfac
increas
fig
suggest
corneum
hydrat
associ
watersolubl
antigen
penetr
skin
water
content
return
level
untreat
skin
within
h
remov
tci
formul
natur
moistur
factor
stratum
corneum
near
epiderm
layer
also
slightli
increas
fig
although
reason
increas
tabl
distribut
antitt
antidt
antibodi
titer
day
day
applic
tci
formul
anti
unclear
critic
chang
skin
compon
cholesterol
turocan
acid
ph
turocan
acid
ph
urea
acid
serin
prolin
data
shown
indic
applic
tci
formul
littl
advers
effect
skin
moreov
amount
glycerin
lactat
acid
ceramid
increas
stratum
corneum
near
skin
surfac
follow
applic
tci
formul
fig
suggest
glycerin
octyldodecyl
lactat
compon
hydrogel
patch
penetr
stratum
corneum
amount
chang
octyldodecyl
lactat
infer
lactat
acid
ceramid
level
octyldodecyl
lactat
consist
lactat
acid
carbon
chain
ceramid
structur
glycerin
humect
hold
water
skin
soften
skin
octyldodecyl
lactat
absorpt
enhanc
disrupt
lipid
bilay
corneum
promot
transmiss
absorpt
materi
thu
assum
compon
penetr
stratum
corneum
act
enhanc
deliveri
antigen
protein
skin
data
demonstr
corneum
swell
disrupt
applic
tci
formul
contribut
enhanc
permeat
antigen
stratum
corneum
clinic
studi
confirm
hydrogel
patch
safe
use
tci
devic
observ
hydrogel
patch
contain
tt
dt
tci
formul
induc
immun
respons
human
without
sever
advers
reaction
although
group
report
develop
tci
system
practic
use
system
compris
gauz
patch
tci
devic
tci
system
use
gauz
patch
inconveni
requir
cold
storag
transport
antigen
solut
well
convent
inject
vaccin
system
system
requir
gauz
patch
satur
antigen
solut
applic
skin
addit
safeti
issu
tci
system
use
gauz
patch
stratum
corneum
must
disrupt
transcutan
deliveri
enough
antigen
induc
immun
respons
hand
system
prepar
manag
tci
formul
like
gener
foment
concentr
antigen
layer
surfac
hydrogel
patch
hydrogel
patch
made
safe
materi
alreadi
appli
human
fact
tci
formul
caus
sever
side
effect
toxoidspecif
antibodi
produc
subject
singl
applic
without
remov
stratum
corneum
moreov
antibodi
titer
higher
year
first
vaccin
day
immun
respons
expect
enhanc
sever
applic
second
applic
tci
formul
increas
antibodi
titer
part
subject
fifth
vaccin
recommend
standard
vaccin
tetanu
diphtheria
toxoid
sever
applic
easytous
tci
system
might
better
formul
inject
vaccin
regard
administr
previous
report
hydrogel
patch
promot
antigen
penetr
stratum
corneum
caus
corneum
hydrat
anim
experi
clarifi
mechan
antigen
permeat
human
analyz
skin
condit
appli
tci
formul
use
vivo
confoc
raman
spectroscopi
demonstr
water
content
stratum
corneum
increas
immedi
patch
applic
addit
hydrat
stratum
corneum
patch
compon
glycerin
octyldodecyl
lactat
penetr
stratum
corneum
humect
stratum
corneum
induc
glycerin
disrupt
lipid
bilay
induc
octyldodecyl
lactat
like
associ
antigen
permeat
unfortun
although
plan
examin
antigen
permeat
stratum
corneum
unabl
obtain
specif
raman
spectra
tt
dt
specul
tci
formul
deliv
antigen
lc
chang
skin
properti
without
destroy
stratum
corneum
physic
barrier
immun
respons
actual
induc
applic
tci
formul
therefor
develop
easytous
tci
formul
induc
immun
respons
without
sever
side
effect
human
number
subject
classifi
doubt
reaction
nonvesicular
posit
reaction
follow
tci
applic
higher
follow
patch
test
assum
erythema
induc
antigenfre
hydrogel
patch
result
applic
adhes
skin
hand
hydrogel
patch
contain
antigen
appli
local
irrit
observ
h
also
h
remov
tci
formul
thought
physic
stimul
inflammatori
reaction
occur
word
antigen
penetr
skin
induc
immun
respons
protect
bodi
one
potenti
reason
immunocompet
cell
stimul
antigen
penetr
skin
subject
subject
report
skin
irrit
either
antitt
dt
antibodi
titer
day
increas
iuml
day
anoth
potenti
reason
subject
alreadi
antibodi
antigen
subject
subject
high
antibodi
titer
dt
day
iuml
thu
infer
irrit
respons
applic
tci
formul
simpli
side
effect
rather
indic
immun
respons
protect
reaction
antigen
penetr
skin
fever
system
symptom
flare
swell
local
advers
event
observ
inject
vaccin
group
vaccin
inject
studi
directli
compar
advers
effect
inject
transcutan
vaccin
base
result
studi
think
like
larg
differ
inject
transcutan
vaccin
therefor
believ
tci
system
abl
overcom
sever
problem
inject
vaccin
achiev
safe
easytous
vaccin
antibodi
titer
increas
signific
effect
detect
pair
ttest
hand
antibodi
titer
subject
increas
even
one
two
applic
almost
subject
alreadi
vaccin
tetanu
diphtheria
infant
assum
subject
increas
antibodi
titer
induc
applic
tci
formul
antibodi
titer
alreadi
maximum
level
antibodi
titer
greater
iuml
report
necessari
prophylaxi
tetanu
diphtherit
neuropathi
day
antitt
antibodi
titer
higher
iuml
subject
antidt
antibodi
titer
higher
iuml
subject
unfortun
explan
could
confirm
vaccin
histori
subject
studi
collect
antibodi
titer
increas
subject
antibodi
titer
lower
iuml
tci
applic
although
antibodi
titer
subject
increas
iuml
suggest
tci
use
hydrogel
patch
induc
littl
immun
respons
primari
vaccin
reason
thought
antigen
penetr
skin
insuffici
induc
immun
respons
analyz
antigen
permeat
anim
experi
although
could
human
skin
hydrogel
patch
contain
ilabel
tt
dt
appli
rat
amount
antigen
distribut
stratum
corneum
antigen
penetr
stratum
corneum
calcul
radioact
use
gamma
counter
data
indic
amount
antigen
penetr
skin
percent
antigen
appli
skin
unpublish
data
suggest
antigendeliveri
amount
tci
formul
small
human
addit
might
individu
differ
antigen
penetr
stratum
corneum
probabl
potenc
immun
respons
like
differ
individu
current
inject
vaccin
contain
aluminum
salt
adjuv
dozen
microgram
antigen
adjuv
would
enhanc
immun
respons
antigen
tci
system
well
inject
increas
antigen
penetr
skin
develop
transcutan
adjuv
might
improv
respons
rate
moreov
cost
may
cut
decreas
antigen
quantiti
use
tci
studi
progress
improv
antigen
penetr
modifi
hydrogel
patch
develop
transcutan
adjuv
activ
immun
system
like
tolllik
receptor
ligand
previou
studi
reveal
tci
system
deliv
antigen
stratum
corneum
seem
enhanc
immun
respons
like
relat
action
lc
analyz
role
lc
detail
investig
characterist
immun
respons
transgen
mice
whose
lc
cell
deplet
evalu
tci
formul
impact
balanc
human
help
defin
characterist
tci
system
determin
addit
applic
hydrogel
patch
exampl
tci
system
might
applic
treat
autoimmun
diseas
correct
balanc
moreov
hydrogel
patch
formul
potenti
wide
varieti
applic
vaccineimmunotherapi
also
drug
deliveri
therapi
diseas
atop
dermat
develop
hydrogel
patch
tci
devic
demonstr
tci
formul
use
hydrogel
patch
could
induc
immun
respons
without
caus
local
system
sever
advers
reaction
human
practic
applic
tci
system
hydrogel
patch
must
improv
manufactur
method
tci
formul
must
establish
easytous
tci
formul
might
applic
mass
treatment
event
outbreak
increas
vaccin
rate
develop
countri
expect
tci
system
innov
vaccin
method
greatli
contribut
decreas
mortal
morbid
infecti
diseas
